https://www.stocktitan.net/news/APMD/apnimed-reports-third-quarter-2026-financial-results-and-provides-tmgd3kqwkj0q.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/APMD/apnimed-reports-third-quarter-2026-financial-results-and-provides-tmgd3kqwkj0q.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/APMD/apnimed-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635-zlwjfvjzxric.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/APMD/apnimed-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635-zlwjfvjzxric.html?utm_source=stocktitan-bluesky&utm_medium=social
• Holder: Shionogi
• Stake: 0 → 7.1% (about $45M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 4 · Schedule 13G
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
• Holder: Shionogi
• Stake: 0 → 7.1% (about $45M)
• About 13G: a passive investor, not seeking to influence the company
• Filed: Nov 4 · Schedule 13G
📊 More at www.elixstocks.com
Educational only. Not investment advice.
#Investing #Stocks
Shares closed at $15.40 Mon: below SMA50, RSI 32.
Hub: www.merlintrader.com/apnimed-apmd...
Not investment advice.
Shares closed at $15.40 Mon: below SMA50, RSI 32.
Hub: www.merlintrader.com/apnimed-apmd...
Not investment advice.
The completed study of AD109 versus placebo in obstructive sleep apnea enrolled 660 patients.
Mon close $15.40: below SMA50, RSI 39.
Hub: www.merlintrader.com/apnimed-apmd...
Not investment advice.
The completed study of AD109 versus placebo in obstructive sleep apnea enrolled 660 patients.
Mon close $15.40: below SMA50, RSI 39.
Hub: www.merlintrader.com/apnimed-apmd...
Not investment advice.
New hub updated: www.merlintrader.com/apnimed-apmd...
New hub updated: www.merlintrader.com/apnimed-apmd...
New hub updated: www.merlintrader.com/apnimed-apmd...
New hub updated: www.merlintrader.com/apnimed-apmd...
October 20, 2026 — Clinical Data Presentation
AD109 follow-up analyses from Phase 3 SynAIRgy and LunAIRo at CHEST 2026; not a new pivotal readout.
🔗 Full details: www.merlintrader.com/apnimed-apmd...
#APMD #Biotech #CHEST2026
October 20, 2026 — Clinical Data Presentation
AD109 follow-up analyses from Phase 3 SynAIRgy and LunAIRo at CHEST 2026; not a new pivotal readout.
🔗 Full details: www.merlintrader.com/apnimed-apmd...
#APMD #Biotech #CHEST2026
https://www.merlintrader.com/apnimed-apmd-stock-hub/
https://www.merlintrader.com/apnimed-apmd-stock-hub/
https://www.stocktitan.net/news/APMD/apnimed-to-present-five-abstracts-including-two-late-breakers-at-9oz9i143t4qq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/APMD/apnimed-to-present-five-abstracts-including-two-late-breakers-at-9oz9i143t4qq.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/APMD/apnimed-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635-xzmtiwdm6ri4.html?utm_source=stocktitan-bluesky&utm_medium=social
https://www.stocktitan.net/news/APMD/apnimed-inc-reports-inducement-grants-under-nasdaq-listing-rule-5635-xzmtiwdm6ri4.html?utm_source=stocktitan-bluesky&utm_medium=social
Moi c’est du badminton qui est prévu cet apmd :)
Moi c’est du badminton qui est prévu cet apmd :)
Bordeaux avec @optimistique33.gayfr.social ✊
ce soir instant de poésie sur les quais 🥰
Bordeaux avec @optimistique33.gayfr.social ✊
ce soir instant de poésie sur les quais 🥰
BTAI: $0.04 (-27.5%)
VOYG: $30.70 (-18.2%)
APMD: $22.04 (-13.6%)
VOR: $19.20 (-12.7%)
CTEV: $25.86 (-12.2%)
More: https://suggestionbox.live/planet-markets
BTAI: $0.04 (-27.5%)
VOYG: $30.70 (-18.2%)
APMD: $22.04 (-13.6%)
VOR: $19.20 (-12.7%)
CTEV: $25.86 (-12.2%)
More: https://suggestionbox.live/planet-markets
- t’es en télétravail cet apmd ?
-oui
-mais c’est le seul apmd où j’ai pas cours ! Pourquoi ? » 😠
Moi aussi je l’aime ❤️
- t’es en télétravail cet apmd ?
-oui
-mais c’est le seul apmd où j’ai pas cours ! Pourquoi ? » 😠
Moi aussi je l’aime ❤️
Pour cet apmd ce n’était pas pour voir une fille je pense. Mais ça viendra aussi :)
Pour cet apmd ce n’était pas pour voir une fille je pense. Mais ça viendra aussi :)